[Schwere Anti-MDA5-Dermatomyositis nach nur milder Covid-19-Infektion]

J Dtsch Dermatol Ges. 2023 Apr:21 Suppl 2:19-21. doi: 10.1111/ddg.15092_g.
[Article in German]
No abstract available

MeSH terms

  • Autoantibodies
  • COVID-19*
  • Dermatomyositis* / diagnosis
  • Dermatomyositis* / drug therapy
  • Humans
  • Interferon-Induced Helicase, IFIH1
  • Lung Diseases, Interstitial*
  • Prognosis
  • Retrospective Studies

Substances

  • Autoantibodies
  • Interferon-Induced Helicase, IFIH1
  • IFIH1 protein, human